The Amp · business building

Your Research.
Amplified.

Peer review proves the science. The Amp takes it to market: partnerships, sales channels, licensing, and funder introductions — brokered for you, with revenue share flowing to the researchers, not to a publisher.

Plug in your paper

Signal Chain

Every request runs the same pipeline. You see your stage; we do the brokering. If a deal generates revenue, the researcher share is agreed in writing before anything is signed.

  1. 01

    INQUIRY

    You tell us the commercialization goal for an accepted paper.

  2. 02

    SCREENING

    We assess market fit, IP posture, and partner appetite.

  3. 03

    MATCHED

    Introductions to partners, licensees, or funders from the directory.

  4. 04

    DEAL

    Terms signed. Revenue share routes to the research team.

Success Stories (pilot cohort)

LICENSING

Perovskite stability chemistry → pilot line

A published passivation method matched with a module manufacturer and a seed funder. Researcher-majority revenue share drafted before any term sheet.

FUNDING

Open genomics model, non-exclusive license

An accepted ML paper explored a commercial API route while keeping academic weights open — with strict non-diagnostic framing.

PARTNERSHIP

Sensor method → environmental services pilot

A drought early-warning method entered screening with a public-sector partner. Amplify the science; keep the credit with the scientists.

The Intake

Open to accepted or published papers only — peer review comes first, always. One request per paper.

Sign in to plug your paper into The Amp.

Sign in